Outcome of Board Meeting held on May 21, 2026
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts less than Nifty 100 and 6.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare approved audited Q4 and FY26 results with strong performance. Consolidated revenue grew 19% to ₹8,37,345 lakhs while consolidated PAT jumped 34% to ₹1,44,241 lakhs versus prior year. Standalone PAT stood at ₹71,661 lakhs. EPS (consolidated annual) improved to ₹14.83 from ₹11.07. Auditors S.R. Batliboi & Co. LLP issued an unmodified (clean) opinion. Exceptional items of ₹4,824 lakhs include ₹3,390 lakhs impact of new Labour Codes and ₹1,434 lakhs stamp duty provision. A tax benefit of ₹14,148 lakhs from the CRL-JHL merger was recognized. Board recommended dividend of ₹2 per share. Other approvals include construction of a ~712-bed hospital in Lucknow, acquisition of Kalinga Hospitals (58.28% stake for ₹29,797 lakhs), and reclassification of Radiant Life Care Hospital Foundation from promoter to public category.
Strong earnings growth with 34% PAT increase is positive for shareholders. The clean audit opinion removes any concern about financial reporting quality. New hospital construction and acquisition signal expansion but involve significant capital deployment.